Gianfranco Mancuso
Palermo, 90146, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer.
Journal: Pulmonary therapy
Published: March 08, 2021
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials.
Journal: BMC cancer
Published: February 20, 2021
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis.
Journal: Ecancermedicalscience
Published: April 23, 2020
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data.
Journal: In vivo (Athens, Greece)
Published: April 08, 2020
Listening understanding and acting (lung): focus on communicational issue in thoracic oncology.
Journal: Translational cancer research
Published: November 28, 2018
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 17, 2012
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 14, 2012
First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 11, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026